Recordati SpA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Recordati SpA with three other
pharmaceutical manufacturers in Europe:
Krka DD Novo Mesto
sales of 1.33 billion Euro [US$1.50 billion]
Vifor Pharma AG
(1.58 billion Swiss Francs [US$1.57 billion]
of which 100%
was Pharmaceutical), and
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
based in Hungary
(445.48 billion Hungarian Forints [US$1.57 billion]
of which 80%
was Pharmaceutical Manufacturing and Sale).
During the year ended December of 2018, sales at
Recordati SpA were 1.35 billion Euro (US$1.53 billion).
increase of 5.0%
versus 2017, when the company's sales were 1.29 billion Euro.
This was the fifth consecutive year of sales increases at Recordati SpA
(and since 2013, sales have increased a total of 44%).